Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Piramal Pharma Q1 net loss narrows to Rs 89 crore

The pharmaceutical company's consolidated net loss contracted to Rs 88.64 crore in Q1 FY25 as against Rs 98.58 crore posted in Q1 FY24.

By: business-standard.com

Jul 26 2024
0
0 Views

Piramal Pharma Q1 net loss narrows to Rs 89 crore

Related

Sun Pharma receives USFDA approval for LEQSELVI (deuruxolitinib) 8 mg tablets

Piramal Pharma Q1 net loss narrows to Rs 89 crore

U P Hotels reports standalone net loss of Rs 0.72 crore in the June 2024 quarter

Sensex spurts 1,103 pts; auto shares gears up

Nelcast consolidated net profit rises 10.86% in the June 2024 quarter

Piramal Pharma reports consolidated net loss of Rs 88.64 crore in the June 2024 quarter

FGP standalone net profit rises 300.00% in the June 2024 quarter

Aro Granite Industries standalone net profit declines 43.18% in the June 2024 quarter

Mahasagar Travels reports standalone net loss of Rs 0.34 crore in the June 2024 quarter

Southern Magnesium & Chemicals standalone net profit rises 270.83% in the June 2024 quarter

Equitas Small Finance Bank standalone net profit declines 86.53% in the June 2024 quarter

Mysore Petro Chemicals consolidated net profit rises 81.64% in the June 2024 quarter

Share this page

Guest Posts by Easy Branches

anchor links ads by Easy Branches

Get Reliable Matka Guessing Forum with our Satta Matka Expert and Get all Matka Chart For Free.

Next

Sun Pharma receives USFDA approval for LEQSELVI (deuruxolitinib) 8 mg tablets